4-CHLORO-2-PHENYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 250mg

Stéarate de butyle, pour la synthèse, 2,5 L, emballage en verre

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, 97%, 250g

2-Bromo-3-fluoro-5-methylpyridine, 95.0%, 5g

(3R,4R)-tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate, 95.0%, 5g

5-BROMO-4-CHLORO-1H-PYRAZOLO[3,4-B]PYRIDINE, 95%, 10g

2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid, 98.0%, 100g

1,7-Dichloroheptan-4-one, 95.0%, 1g

3-allyl-6-(methylsulfonyl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 250mg

4-Fluoro-2-nitrobenzamide, 95.0%, 10g

9-Iodoanthracene, 95.0%, 250mg

Phthalonitrile>99.0%(GC)100g

(R)-2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthalene, 97%, 25g